Medicare Enrolled
Florida Board Action on Record
The Florida Department of Health has flagged this practitioner's license with a board action.
Verify on FL DOH →
Dr. Daniel Kaplon
Urology Physician · Sarasota, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kaplon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kaplon?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kaplon
Dr. Daniel Kaplon is an urology physician in Sarasota, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Kaplon performed 7,373 Medicare services across 4,248 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kaplon received a total of $8,115 from 33 pharmaceutical and/or device companies across 120 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kaplon is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 17% volume in FL
$8,115 industry payments
Florida License Status
FL DOH · MQA1
Active license
Yes
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 104278 | Clear | January 31, 2027 | ⚠ |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗7,373
Medicare services
Top 17% in FL for urology physician
4,248
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~410 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
1,800 | $5 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,391 | $64 | $151 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,346 | $86 | $219 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
801 | $2 | $6 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
457 | $178 | $454 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
210 | $108 | $333 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 210 | $3 | $12 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
120 | $38 | $108 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
91 | $94 | $506 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
91 | $24 | $113 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 78 | $133 | $550 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
67 | $41 | $96 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
62 | $66 | $216 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
58 | $580 | $1,416 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
47 | $103 | $1,270 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
41 | $239 | $726 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
38 | $879 | $3,399 |
| Endoscopic removal of pelvic lymph nodes, bilateral A surgical procedure to remove lymph nodes from both sides of the pelvis using an endoscope. This minimally invasive technique involves making small incisions to access and excise the tissue. |
36 | $265 | $1,525 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
36 | $342 | $882 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
33 | $101 | $281 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
31 | $228 | $611 |
| Imaging guidance for procedure, 60 minutes or less Use of imaging technology to guide a medical procedure. This service lasts 60 minutes or less. |
30 | $12 | $32 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
27 | $25 | $67 |
| Hormone pellet insertion under the skin A small hormone pellet is placed just beneath the skin to release medication slowly over time. |
26 | $72 | $197 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
26 | $64 | $211 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
25 | $1,006 | $1,792 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
20 | $63 | $148 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
18 | $568 | $1,619 |
| Bladder tumor removal via endoscope This procedure involves using an endoscope to destroy or remove a large growth from the bladder. |
17 | $303 | $995 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
17 | $298 | $637 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
15 | $27 | $369 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
15 | $7 | $36 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
15 | $18 | $51 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
14 | $266 | $620 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
14 | $139 | $374 |
| Ureteral stent insertion via cystoscopy A tube is placed into the ureter using an endoscope inserted through the bladder. |
14 | $89 | $696 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
14 | $40 | $86 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
11 | $112 | $563 |
| Laparoscopic partial prostate removal A minimally invasive surgical procedure to remove part of the prostate gland using a laparoscope. |
11 | $834 | $2,129 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.1% high complexity
30.9% medium
67.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,115
Total received (2018-2024)
Avg $1,159/year across 7 years
Top 26% in FL for urology physician
33
Companies
120
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,366 (53.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,749 (46.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$137
2023
$4,115
2022
$2,405
2021
$116
2020
$103
2019
$596
2018
$644
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Intuitive Surgical, Inc.
$5,854
Boston Scientific Corporation
$273
Astellas Pharma US Inc
$248
ABBVIE INC.
$206
NeoTract Inc.
$187
PFIZER INC.
$149
PROCEPT BioRobotics Corporation
$145
Retrophin, Inc.
$128
Janssen Biotech, Inc.
$109
Ethicon US, LLC
$92
Novartis Pharmaceuticals Corporation
$77
Allergan Inc.
$74
United Service Solutions LLC
$68
UroGen Pharma, Inc.
$47
Allergan, Inc.
$46
Laborie Medical Technologies Corp.
$42
180 Medical, Inc.
$37
Endo Pharmaceuticals Inc.
$34
Axonics, Inc.
$28
Wilmington Medical Supply, Inc.
$28
C. R. Bard, Inc. & Subsidiaries
$25
UROGEN PHARMA, INC.
$24
Smith+Nephew, Inc.
$22
Telix Pharmaceuticals
$20
TOLMAR Pharmaceuticals, Inc.
$20
Antares Pharma, Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$18
Acerus Pharmaceuticals Corporation
$17
Photocure Inc
$17
Dendreon Pharmaceuticals LLC
$17
BAXTER HEALTHCARE
$15
Amgen Inc.
$14
Aytu BioScience, Inc
$14
Top 3 companies account for 78.6% of total payments
Associated products mentioned in payments ›
(815) Thiola · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · Axonics · BOTOX · BOTOX THERAPEUTIC · Bulkamid · Cysview · DA VINCI SP · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · FLOSEAL · GENERAL - KIDNEY STONE DISEASE · GENTLECATH · GentleCath · ILLUCCIX · JELMYTO · LithoVue · MYRBETRIQ · NEUWAVE Flex Microwave Ablation System · NOCDURNA · Natesto · Nubeqa · PLUVICTO · PROVENGE · Prolia · REZUM · SWISS LITHOCLAST · SpaceOAR System · Spectra · Stravix · TOVIAZ · UroLift · XIAFLEX · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (54%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $110 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
37
Per 100K population
8.2
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kaplon is a clinical cardiology specialist, with above-average Medicare volume (top 17% in FL), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kaplon experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Kaplon performed 1,800 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kaplon receive payments from pharmaceutical companies?
Yes. Dr. Kaplon received a total of $8,115 from 33 companies across 120 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kaplon's costs compare to other urology physicians in Sarasota?
Dr. Kaplon's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kaplon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Sarasota
Browse urology physicians in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in FL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in FL
Which FL urology physicians receive the most from drug and device companies.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology